These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10975769)

  • 21. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
    Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
    Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of duodenal ulcer with pantoprazole. A multicenter study].
    Fric P; Huslarová A; Dítĕ P; Jirásek V; Roth Z; Svoboda J; Drazná E; Dufek V; Dvorák M; Kunovská M; Münzová H; Pelech T; Petrtýl J; Zádorová Z; Zavoral M
    Cas Lek Cesk; 1996 Dec; 135(23):758-61. PubMed ID: 9005122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
    N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
    Escourrou J; Deprez P; Saggioro A; Geldof H; Fischer R; Maier C
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1481-91. PubMed ID: 10571605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
    Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
    Cullen D; Bardhan KD; Eisner M; Kogut DG; Peacock RA; Thomson JM; Hawkey CJ
    Aliment Pharmacol Ther; 1998 Feb; 12(2):135-40. PubMed ID: 9692687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
    Van Rensburg CJ; Honiball PJ; Van Zyl JH; Grundling HD; Eloff FP; Spies SK; Simjee AE; Theron I; Fischer R; Louw JA
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1023-8. PubMed ID: 10468676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
    Judmaier G; Koelz HR
    Aliment Pharmacol Ther; 1994 Feb; 8(1):81-6. PubMed ID: 8186350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
    Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
    Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of pantoprazole on non-variceal bleeding].
    Wu XP; He JR; Wang CL; Ling QH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):361-2. PubMed ID: 12206002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.
    Shim KN; Kim JI; Kim N; Kim SG; Jo YJ; Hong SJ; Shin JE; Kim GH; Park KS; Choi SC; Kwon JG; Kim JH; Kim HJ; Kim JW
    Korean J Intern Med; 2019 Sep; 34(5):1008-1021. PubMed ID: 29847892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
    J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
    Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
    Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.